Nader N Hanna

Summary

Affiliation: University of Maryland
Country: USA

Publications

  1. pmc Does the type of first-line regimens influence the receipt of second-line chemotherapy treatment? An analysis of 3211 metastatic colon cancer patients
    Zhiyuan Zheng
    Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD
    Cancer Med 3:124-33. 2014
  2. pmc Impact of venous thromboembolism on mortality of elderly Medicare patients with stage III colon cancer
    Nader Hanna
    Director of Clinical Operations, Division of General and Oncologic Surgery, University of Maryland School of Medicine, 22 South Greene Street, Baltimore, MD 21201, USA
    Oncologist 17:1191-7. 2012
  3. doi request reprint Phase 1/2a, dose-escalation, safety, pharmacokinetic and preliminary efficacy study of intratumoral administration of BC-819 in patients with unresectable pancreatic cancer
    N Hanna
    Department of Surgery, Division of Surgical Oncology, University of Maryland School of Medicine, Baltimore, MD 21201, USA
    Cancer Gene Ther 19:374-81. 2012
  4. doi request reprint Palliative surgical oncology
    Nader N Hanna
    Division of Surgical Oncology, University of Maryland School of Medicine, Baltimore, MD 21201, USA
    Surg Clin North Am 91:343-53, viii. 2011
  5. doi request reprint Comparative analysis of various prognostic nodal factors, adjuvant chemotherapy and survival among stage III colon cancer patients over 65 years: an analysis using surveillance, epidemiology and end results (SEER)-Medicare data
    N N Hanna
    Department of Surgery, University of Maryland, Baltimore, Maryland 21201, USA
    Colorectal Dis 14:48-55. 2012
  6. ncbi request reprint Dual induction of the Epo-Egr-TNF-alpha- plasmid in hypoxic human colon adenocarcinoma produces tumor growth delay
    Rabih M Salloum
    Department of Surgery, University of Rochester School of Medicine, 601 Elmwood Avenue, Rochester, New York 14642 8410, USA
    Am Surg 69:24-7. 2003
  7. doi request reprint Assessment of neoadjuvant chemotherapy on operative parameters and outcome in patients with peritoneal dissemination from high-grade appendiceal cancer
    Keli M Turner
    Division of General and Oncologic Surgery, Department of Surgery and the Marlene and Stewart Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA
    Ann Surg Oncol 20:1068-73. 2013
  8. ncbi request reprint Tumour antigen targeted monoclonal antibodies incorporating a novel multimerisation domain significantly enhance antibody dependent cellular cytotoxicity against colon cancer
    Ajay Jain
    Baltimore Veterans Administration Medical Center, Section of Surgical Oncology, and Research and Development Service, 10 N Greene Street, 5C Surgical Services Area, Baltimore, MD 21201, USA Division of General and Oncologic Surgery, University of Maryland School of Medicine, 22 S Greene Street, Room S4B12, Baltimore, MD 21201, USA Department of Otorhinolaryngology Head and Neck Surgery, University of Maryland School of Medicine, 16 S Eutaw Street, Baltimore, MD 21201, USA Electronic address
    Eur J Cancer 49:3344-52. 2013
  9. ncbi request reprint Ovarian neoplasms in patients with colorectal cancer: understanding the role of prophylactic oophorectomy
    Nader N Hanna
    Department of Surgery, Surgical Oncology Service, Markey Cancer Center, University of Kentucky, Lexington, USA
    Clin Colorectal Cancer 3:215-22. 2004

Collaborators

Detail Information

Publications9

  1. pmc Does the type of first-line regimens influence the receipt of second-line chemotherapy treatment? An analysis of 3211 metastatic colon cancer patients
    Zhiyuan Zheng
    Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD
    Cancer Med 3:124-33. 2014
    ..Elderly mCC patients, their health care providers, and policy makers will benefit from new evidence about the impact of sequencing of treatment lines...
  2. pmc Impact of venous thromboembolism on mortality of elderly Medicare patients with stage III colon cancer
    Nader Hanna
    Director of Clinical Operations, Division of General and Oncologic Surgery, University of Maryland School of Medicine, 22 South Greene Street, Baltimore, MD 21201, USA
    Oncologist 17:1191-7. 2012
    ..Adverse events such as venous thromboembolism (VTE) affect overall survival times and the net clinical benefit of cancer management strategies...
  3. doi request reprint Phase 1/2a, dose-escalation, safety, pharmacokinetic and preliminary efficacy study of intratumoral administration of BC-819 in patients with unresectable pancreatic cancer
    N Hanna
    Department of Surgery, Division of Surgical Oncology, University of Maryland School of Medicine, Baltimore, MD 21201, USA
    Cancer Gene Ther 19:374-81. 2012
    ..BC-819 given locally in combination with systemic chemotherapy may provide an additional therapeutic benefit for the treatment of pancreatic cancer...
  4. doi request reprint Palliative surgical oncology
    Nader N Hanna
    Division of Surgical Oncology, University of Maryland School of Medicine, Baltimore, MD 21201, USA
    Surg Clin North Am 91:343-53, viii. 2011
    ..This is leading to a new form of surgical practice in which the emphasis is on relief of present or anticipated symptoms, even if the interventions do not prolong a patient's life span...
  5. doi request reprint Comparative analysis of various prognostic nodal factors, adjuvant chemotherapy and survival among stage III colon cancer patients over 65 years: an analysis using surveillance, epidemiology and end results (SEER)-Medicare data
    N N Hanna
    Department of Surgery, University of Maryland, Baltimore, Maryland 21201, USA
    Colorectal Dis 14:48-55. 2012
    ..It is unknown whether the cancer-specific survival benefit of chemotherapy differs across these nodal prognostic categories...
  6. ncbi request reprint Dual induction of the Epo-Egr-TNF-alpha- plasmid in hypoxic human colon adenocarcinoma produces tumor growth delay
    Rabih M Salloum
    Department of Surgery, University of Rochester School of Medicine, 601 Elmwood Avenue, Rochester, New York 14642 8410, USA
    Am Surg 69:24-7. 2003
    ..Regional tumor hypoxia can be exploited successfully to induce tumor growth delay, enhance local control, and enhance the therapeutic ratio...
  7. doi request reprint Assessment of neoadjuvant chemotherapy on operative parameters and outcome in patients with peritoneal dissemination from high-grade appendiceal cancer
    Keli M Turner
    Division of General and Oncologic Surgery, Department of Surgery and the Marlene and Stewart Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA
    Ann Surg Oncol 20:1068-73. 2013
    ..The impact of neoadjuvant chemotherapy on operative cytoreduction (CRS) and intraperitoneal chemotherapy (HIPEC) and patient survival was reviewed...
  8. ncbi request reprint Tumour antigen targeted monoclonal antibodies incorporating a novel multimerisation domain significantly enhance antibody dependent cellular cytotoxicity against colon cancer
    Ajay Jain
    Baltimore Veterans Administration Medical Center, Section of Surgical Oncology, and Research and Development Service, 10 N Greene Street, 5C Surgical Services Area, Baltimore, MD 21201, USA Division of General and Oncologic Surgery, University of Maryland School of Medicine, 22 S Greene Street, Room S4B12, Baltimore, MD 21201, USA Department of Otorhinolaryngology Head and Neck Surgery, University of Maryland School of Medicine, 16 S Eutaw Street, Baltimore, MD 21201, USA Electronic address
    Eur J Cancer 49:3344-52. 2013
    ..These data suggest that high avidity cross-linking of multiple tumour surface antigens and multiple NK cell associated FcγRIIIa molecules can enhance ADCC and partially overcome impaired ADCC by FF genotype individuals in vitro...
  9. ncbi request reprint Ovarian neoplasms in patients with colorectal cancer: understanding the role of prophylactic oophorectomy
    Nader N Hanna
    Department of Surgery, Surgical Oncology Service, Markey Cancer Center, University of Kentucky, Lexington, USA
    Clin Colorectal Cancer 3:215-22. 2004
    ....